ALL-IN-ONE UTI EMERGENCY KIT- methenamine, sodium salicylate, and phenazopyridine hydrochloride 
UQORA INC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Uqora All-In-One UTI Emergency Kit

Drug Facts

Active ingredients (in each tablet)Purpose
Methenamine 162mgAntibacterial

Sodium Salicylate 162.5mg (NSAID)*

*nonsteroidal anti-inflammatory drug

Analgesic (pain reliever)

Active ingredient (in each tablet)

Purpose
Phenazopyridine Hydrochloride 99.5mgUrinary Tract Analgesic

Uses

UTI Infection Control

Temporarily relieves:

  • pain and burning
  • frequency and urgency of urination

UTI Pain Relief

Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days; see Directions.

Warnings

Reye's Syndrome (UTI Infection Control Only)

Reye’s syndrome: Children and teenagers who have or are recovering from chicken pox or flu-like symptoms should not use this
product. When using this product, if changes in behavior with nausea and vomiting occur, consult a doctor because these symptoms could be an early sign of Reye’s syndrome, a rare but serious illness.

Stomach Bleeding Warning (UTI Infection Control Only)

Stomach bleeding warning: This product contains a nonsteroidal anti-inflammatory drug (NSAID), which may cause stomach bleeding. The chance is higher if you

  • are 60 or older
  • have stomach ulcers or bleeding problems
  • take a blood thinning (anticoagulant) or steroid drug
  • take other drugs containing an NSAID (aspirin, ibuprofen, naproxen, or others)
  • have 3 or more alcoholic drinks every day while using this product
  • take more or for a longer time than directed

Do Not Exceed (UTI Pain Relief Only)

Do not exceed recommended dosage

Do Not Use

Do not use:

  • If you are allergic to salicylates (including aspirin) ( UTI Infection Control only)
  • If you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your doctor ( UTI Pain Relief only)

Ask A Doctor Before Use

Ask a doctor before use if you have:

  • frequent, burning urination for the first time (UTI Infection Control only)
  • the stomach bleeding warning applying to you (UTI Infection Control only)
  • history of stomach problems, such as heartburn (UTI Infection Control only)
  • high blood pressure (UTI Infection Control only)
  • heart disease (UTI Infection Control only)
  • liver cirrhosis (UTI Infection Control only)
  • bleeding problems (UTI Infection Control only)
  • diuretic use (UTI Infection Control only)
  • ulcers (UTI Infection Control only)
  • kidney disease
  • a sodium restricted diect (UTI Infection Control only)
  • reached age 60 or older (UTI Infection Control only)
  • allergies to foods, preservatives or dyes (UTI Pain Relief only)
  • had a hypersensitive reaction to phenazopyridine (UTI Pain Relief only)

Ask A Doctor Or Pharmacist Before Use (UTI Infection Control Only)

Ask a doctor or pharmacist before use if you are:

  • taking any other drug containing an NSAID (prescription or non-prescription)
  • taking a blood thinning (anticoagulant), steroid, diabetes, gout or arthritis drug

When Using This Product

When using this product:

  • do not take more than the recommended dosage (UTI Infection Control only)
  • stomach upset may occur, taking this product with or after meals may reduce stomach upset (UTI Pain Relief only)
  • your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items. (UTI Pain Relief only)

Stop Use And Ask A Doctor

Stop use and ask a doctor if:

  • product has been used for 3 days (UTI Infection Control only)
  • ringing in the ears (UTI Infection Control only)
  • you experience any of the following signs of stomach bleeding: ■ feel faint ■ vomit blood ■ have bloody or black stool ■ have stomach pain or upset that gets worse or lasts (UTI Infection Control only)
  • your symptoms last for more than 2 days (UTI Pain Relief only)
  • you suspect you are having an adverse reaction to the medication (UTI Pain Relief only)

Long Term Administration (UTI Pain Relief Only)

Long-term administration of phenazopyridine hydrochloride has induced neoplasia in rats (large intestine) and mice (liver). Although
no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted.

If Pregnant or Breast Feeding


UTI Infection Control

If pregnant or breast feeding, ask a health professional before use. It is especially important not to use this product (which contains sodium salicylate) during the last 3 months of pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.

UTI Pain Relief

If pregnant or breast feeding, ask a health professional before use.

Keep Out Of The Reach Of Children

Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away 1-800-222-1222

Directions

UTI Infection Control

Adults and children 12 years and over:

  • take 2 tablets with a full glass of water 3 times a day. Drink plenty of fluids.
  • Do not use for more than a 3 day period unless directed by a doctor.
Children under 12 years: ask a doctor.

UTI Pain Relief

Adults and children 12 years and over:

  • take 2 tablets 3 times daily with a full glass of water, with or after meals as needed
  • Do not use for more than 2 days (12 tablets) without consulting a doctor.
Children under 12 years: consult a doctor

Other Information

UTI Infection Control

  • each tablet contains: sodium 24.4 mg
  • store at 59-86°F (15-30°C) in a cool dry place
  • protect from sunlight
  • Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal is open or damaged

UTI Pain Relief

  • this product may stain contact lenses
  • this product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests
  • store at room temperature 15°-30°C (59°-86°F) in a dry place and protect from light
  • Tamper evident: tablets sealed in blisters. Do not use if blister foil or seal is open or damaged

Inactive Ingredients

UTI Infection Control

benzoic acid, croscarmellose sodium, fd&c red #40, fd&c yellow #6, hypromellose, magnesium stearate, methacrylic acid-ethyl acrylate copolymer, microcrystalline cellulose, silicon dioxide, stearic acid, sodium bicarbonate, sodium lauryl sulfate, talc, titanium dioxide, triacetin, triethyl citrate

UTI Pain Relief

corn starch, croscarmellose sodium, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, sodium starch glycolate, talc and triacetin.

Distributed by Uqora, Inc.

3043 4th Avenue, San Diego, CA 92103

support@uqora.com

For questions or concerns please contact (888) 313-1372

Additional Items

2 diagnostic UTI test strips (Directions Enclosed)

Other information

Principal Display Panel

uqora

Urinary Care

3-in-1 Convenience Kit

ALL-IN-ONE

UTI EMERGENCY KIT

2 Day Supply Includes:

Test Strips

Infection Control

Pain Relief

Packaged for convenience. Not intended to replace medical care.

Emergency Kit Carton

ALL-IN-ONE UTI EMERGENCY KIT 
methenamine, sodium salicylate, and phenazopyridine hydrochloride kit
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73712-500
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73712-500-241 in 1 CARTON; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)10/17/2022
Quantity of Parts
Part #Package QuantityTotal Product Quantity
Part 11 BLISTER PACK 12 
Part 21 BLISTER PACK 12 
Part 1 of 2
UQORA ANTIBACTERIAL PLUS URINARY PAIN RELIEF 
methenamine, sodium salicylate tablet
Product Information
Item Code (Source)NDC:73712-804
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
METHENAMINE (UNII: J50OIX95QV) (METHENAMINE - UNII:J50OIX95QV) METHENAMINE162 mg
SODIUM SALICYLATE (UNII: WIQ1H85SYP) (SALICYLIC ACID - UNII:O414PZ4LPZ) SODIUM SALICYLATE162.5 mg
Inactive Ingredients
Ingredient NameStrength
SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
BENZOIC ACID (UNII: 8SKN0B0MIM)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER (1:1) TYPE A (UNII: NX76LV5T8J)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
TRIACETIN (UNII: XHX3C3X673)  
Product Characteristics
ColorredScoreno score
ShapeROUNDSize11mm
FlavorImprint Code PH061
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73712-804-1212 in 1 BLISTER PACK; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other10/17/2022
Part 2 of 2
UQORA MAXIMUM STRENGTH URINARY PAIN RELIEF 
phenazopyridine hydrochloride tablet
Product Information
Item Code (Source)NDC:73712-113
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17) (PHENAZOPYRIDINE - UNII:K2J09EMJ52) PHENAZOPYRIDINE HYDROCHLORIDE99.5 mg
Inactive Ingredients
Ingredient NameStrength
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G)  
POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
TALC (UNII: 7SEV7J4R1U)  
TRIACETIN (UNII: XHX3C3X673)  
STARCH, CORN (UNII: O8232NY3SJ)  
Product Characteristics
ColorbrownScoreno score
ShapeOVALSize9mm
FlavorImprint Code p99
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:73712-113-1212 in 1 BLISTER PACK; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other10/17/2022
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other10/17/2022
Labeler - UQORA INC (022730893)
Establishment
NameAddressID/FEIBusiness Operations
Pharbest557054835manufacture(73712-500)

Revised: 10/2022
Document Id: ebde96d2-e1f3-26b1-e053-2a95a90a2fb1
Set id: ebde96d2-e1f2-26b1-e053-2a95a90a2fb1
Version: 1
Effective Time: 20221017
 
UQORA INC